insights_auto
Outlook: 28.6% bullish·3.6% bearish
Go to analysischevron_right
GSK:NYSE
GSK plc
US$ ४७.७६
arrow_downward
-०.१३%(-०.०६०) 1D
US$ ४७.९६
arrow_upward
+०.४१% (+०.२०)bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०२ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
US$ ४८.२१
High
US$ ४८.७४
Low
US$ ४७.७०
Mkt. cap
९७.०५ अरब
Avg. vol.
४५.५६ लाख
Volume
२७.४० लाख
Dividend
३.८४%
Quarterly dividend
US$ ०.४६
Ex-dividend date
२०२६ नोभेम्बर १२
P/E ratio
१७.०८
52-wk high
US$ ६१.७०
52-wk low
US$ ४५.८२
EPS
US$ २.८०
Beta
०.२०
Shares outstanding
२.०२ अरब
No. of employees
६७ हजार
Open
US$ ४८.२१
High
US$ ४८.७४
Low
US$ ४७.७०
Mkt. cap
९७.०५ अरब
Avg. vol.
४५.५६ लाख
Volume
२७.४० लाख
Dividend
३.८४%
Quarterly dividend
US$ ०.४६
Ex-dividend date
२०२६ नोभेम्बर १२
P/E ratio
१७.०८
52-wk high
US$ ६१.७०
52-wk low
US$ ४५.८२
EPS
US$ २.८०
Beta
०.२०
Shares outstanding
२.०२ अरब
No. of employees
६७ हजार
News stories
From web sources and news partners
24/7 Wall St.
·
१ घण्टा पहिले
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Crypto Briefing
·
२ घण्टा पहिले
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
Traders Union
·
३ घण्टा पहिले
Ryan Detrick: S&P 500 rose after seven-day losing streak in 16 out of 17 years since 1978
TradingView
·
४ घण्टा पहिले
Yardeni Trims S&P 500 Year-End Forecast Again, Says Bear Market Is Unlikely
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOEmma Walmsley | Emma Walmsley
Employees६६.८ हजार
Founded२००० डिसेम्बर २७
Headquarters-
SectorHealth Care
Industry-
Websitegsk.com